Virica Biotech Inc. — Form D
Virica Biotech Inc. of OTTAWA, A6, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-26. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-01-26
- Form: D
- Accession: 0001140361-24-004027
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 2
- Date of first sale: 2024-01-22
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-503596
Issuer
- Name: Virica Biotech Inc.
- CIK: 0001892496
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2018
- Address: 7 BAYVIEW STATION ROAD, OTTAWA, A6, K1Y 2C5
- Phone: 613-737-8899
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Daniella Kranjac | Director | New York, NY |
| Susan Dexter | Director | Ottawa, A6 |
| Jean-Simon Dr. Diallo | Director | Ottawa, A6 |
| Jean-Simon Dr. Diallo | Executive Officer | Ottawa, A6 |
| Ella Korets-Smith | Executive Officer | Ottawa, A6 |
| Ken Newport | Director | Ottawa, A6 |
| Ken Newport | Executive Officer | Ottawa, A6 |
Other filings by this issuer (3)
More